# Effect of Hemp-CBD on Patients With CIPN

> **NCT04398446** · PHASE2 · UNKNOWN · sponsor: **Main Line Health** · enrollment: 56 (actual)

## Conditions studied

- Chemotherapy-induced Peripheral Neuropathy
- Colorectal Cancer Stage II
- Colorectal Cancer Stage III
- Breast Cancer
- Ovarian Cancer
- Uterine Cancer
- Pancreatic Cancer

## Interventions

- **DRUG:** Hemp-based CBD
- **OTHER:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04398446
- **Lead sponsor:** Main Line Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-27
- **Primary completion:** 2022-11-30
- **Final completion:** 2023-04-01
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2022-09-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04398446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04398446, "Effect of Hemp-CBD on Patients With CIPN". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04398446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*